Talaris Therapeutics, Inc. (TALS) Financials
Stock symbol TALS is outdated, potentially delisted? Maybe it is available on other exchange?
TALS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-06-30 | 159.1 million | 10.7 million |
| 2023-03-31 | 172.6 million | 10.9 million |
| 2022-12-31 | 193.7 million | 13.7 million |
| 2022-09-30 | 206.5 million | 11.7 million |
TALS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-06-30 | -14.9 million | 1.2 million |
| 2023-03-31 | -17.2 million | 3.7 million |
| 2022-12-31 | -14.1 million | 3.1 million |
| 2022-09-30 | -13.8 million | 3.0 million |
TALS Net Income
No data available :(
TALS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-06-30 | 152.3 million | - | 1.0 million |
| 2023-03-31 | 165.8 million | - | 1.3 million |
| 2022-12-31 | 181.3 million | - | 2.9 million |
| 2022-09-30 | 193.9 million | - | 3.1 million |
TALS Shares Outstanding
TALS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-06-30 | 221000 | 4.1 million | 6.0 million | - |
| 2023-03-31 | 320000 | 13.4 million | 6.2 million | - |
| 2022-12-31 | 269000 | 14.6 million | 5.2 million | - |
| 2022-09-30 | 341000 | 15.0 million | 4.8 million | - |
TALS Cost of Revenue
No data available :(
TALS
Price: $2.72
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.8 million
Market Capitalization: 125.7 million